Skip to content Cerevel
  • About Cerevel
    • Unraveling the mysteries of the brain
    • Leadership team
  • Our Programs
    • Emraclidine
    • Darigabat
    • Tavapadon
    • CVL-871
  • Our Science
    • Our scientific strategy
    • Our pipeline
    • Healthcare Professionals
      • Publications
      • Congresses
  • Investors & Media
    • Overview
    • News & Events
      • News & Announcements
      • Events
    • Presentations
    • Stock
      • Stock quote & chart
      • Historic price lookup
      • Investment calculator
      • Analyst coverage
    • Financials
      • SEC filings
      • Annual reports
      • Quarterly results
    • Governance
      • Documents Charters
      • Leadership team
      • Committee Composition
    • Resources
      • Investor FAQs
      • Email alerts
      • Investor & Media Contact
  • Careers
    • Working at Cerevel Therapeutics
    • Open Positions
    • Fellowship Programs
  • Contact Us
Cerevel
  • About Cerevel
    • Unraveling the mysteries of the brain
    • Leadership team
  • Our Programs
    • Emraclidine
    • Darigabat
    • Tavapadon
    • CVL-871
  • Our Science
    • Our scientific strategy
    • Our pipeline
    • Healthcare Professionals
  • Investors & Media
    • Overview
    • News & Events
    • Presentations
    • Stock
    • Financials
    • Governance
    • Resources
  • Careers
    • Working at Cerevel Therapeutics
    • Open Positions
    • Fellowship Programs
  • Contact Us
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
Cerevel
  • Terms of Use
  • Privacy Policy
  • FCOI
  • Early Access Program (EAP) Policy

© 2023 Cerevel Therapeutics

CEREVEL and the CEREVEL logo are trademarks of Cerevel

Therapeutics. All Rights Reserved.

You are now leaving cerevel.com, a website provided by Cerevel Therapeutics. The content displayed on external websites is not controlled by Cerevel, and Cerevel assumes no responsibility for the information or statements on external websites.